Global Infectious Disease Diagnostics Market Growth (Status and Outlook) 2025-2031

According to this study, the global Infectious Disease Diagnostics market size will reach US$ 5088 million by 2031.

Infectious disease diagnostics are medical tests and assays used to identify infectious agents, such as bacteria, viruses, and parasites, in patient samples. They play a crucial role in early detection and effective management of infectious diseases.

The market for infectious disease diagnostics is driven by the increasing prevalence of infectious diseases and the need for accurate and rapid diagnostic solutions to control disease outbreaks. The market"s growth is also influenced by technological advancements, such as molecular diagnostics and point-of-care testing.

LPI (LP Information)' newest research report, the “Infectious Disease Diagnostics Industry Forecast” looks at past sales and reviews total world Infectious Disease Diagnostics sales in 2024, providing a comprehensive analysis by region and market sector of projected Infectious Disease Diagnostics sales for 2025 through 2031. With Infectious Disease Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Infectious Disease Diagnostics industry.

This Insight Report provides a comprehensive analysis of the global Infectious Disease Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Infectious Disease Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Infectious Disease Diagnostics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infectious Disease Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infectious Disease Diagnostics.

This report presents a comprehensive overview, market shares, and growth opportunities of Infectious Disease Diagnostics market by product type, application, key players and key regions and countries.

Segmentation by Type:
Molecular Diagnostic Technique
Traditional Diagnostic Technique

Segmentation by Application:
Hepatitis C
Hepatitis B
Tuberculosis (TB)
Acquired Immunodeficiency Syndrome (AIDS)
Human Papillomavirus (HPV)
Methicillin-resistant Staphylococcus Aureus (MRSA)

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bio Mérieux SA
Roche Diagnostics
Abbott Laboratories
Thermo Fischer Scientific
BD
Bio-Rad Laboratories
Abbott
Danaher
Johnson and Johnson
Guangzhou Wondfo Biotech Co.,Ltd.
Getein Biotech, Inc.
Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
BGI Genomics Co.,Ltd.
Maccura Biotechnology Co.,Ltd.
Daan Gene
Beijing Strong Biotechnologies,Inc
Shanghai Kehua Bio-Engineering Co.,Ltd.
Guangdong Hybribio Biotech Co.,Ltd.
Shanghai Runda Medical Technology Co.,Ltd.
Tellgen Corporation

Please note: The report will take approximately 2 business days to prepare and deliver. Show more